Among them, six laboratory parameters (except for NF-κB1, caspase-1, BAX, and NGAL normalized counts) exhibited the following intergroup differences (Table 3): Hb and neutrophil counts were significantly lower in the AML and MDS groups than those in the MPN and control groups. The gene discussed is NFKB1; the disease is myeloproliferative disorder.